A Case of a Novel Perforin Gene Variant in Severe Familial Hemophagocytic Lymphohistiocytosis Type 2 (FHL2)
Case Reports in Hematology · 2026-01 · 2026 (1)
DOI: 10.1155/crh/1949986 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Hematology, online erschienen am 09.03.2026. Verfasst von Hiroshi Yamauchi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan, chiba-u.ac.jp. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome caused by excessive cytokine release from activated T cells and macrophages. Primary HLH, or familial HLH (FHL), results from genetic mutations affecting cytotoxic lymphocyte function. Case Report We present a case of FHL Type 2 (FHL2) caused by compound heterozygous variants in the PRF1 gene, including one novel missense variant of p.Ala21Val (A21V). A 5‐month‐old boy presented with persistent fever, pancytopenia, coagulopathy, hepatosplenomegaly, and elevated ferritin, meeting the HLH‐2004 diagnostic criteria. Bone marrow revealed hemophagocytosis, and NK cell activity was markedly reduced. Genetic analysis identified compound heterozygous PRF1 variants: A21V and p.Pro16Ser (P16S). Flow cytometric analysis demonstrated markedly reduced PRF1 protein expression in the patient’s NK cells. The patient was treated with etoposide, dexamethasone palmitate, and cyclosporine, followed by cord blood transplantation. The patient has been in remission for over a year.
Discussion
The PRF1 A21V variant has not been described in the public database or the literature and is therefore considered a novel pathogenic variant for FHL2 with functional validation. Although the PRF1 P16S variant has been previously reported in the heterozygous state in an adult patient with primary HLH, our findings provide functional and clinical evidence supporting a contributory role of the P16S variant in autosomal recessive early‐onset FHL2 when present in trans with the novel A21V variant.
Conclusion
We identified a previously unreported PRF1 variant, A21V, and provided the first functional evidence of impaired perforin expression associated with A21V/P16S, highlighting the importance of functional validation of rare PRF1 variants in FHL2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan, chiba-u.ac.jp.
- Clinical Genetics, Chiba University Hospital, Chiba, Japan, chiba-u.ac.jp.
- Department of Allergy and Clinical Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan, chiba-u.ac.jp.
- Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan, kyoto-u.ac.jp.
ORCID-Profile: Moeko Hino, Kazuyuki Meguro, Taiji Nakano, Takahiro Aoki, Takeshi Yamamoto, Hironori Sato, Hiromichi Hamada
Zitieren
APA
Yamauchi, H., Hino, M., Meguro, K., Nakano, T., Aoki, T., Yamashita, Y., Okunushi, T., Yamamoto, T., Sato, H., Yasumi, T., Hirata, Y., Shibata, H., Nakajima, H., & Hamada, H. (2026). A Case of a Novel Perforin Gene Variant in Severe Familial Hemophagocytic Lymphohistiocytosis Type 2 (FHL2). Case Reports in Hematology, 2026(1). https://doi.org/10.1155/crh/1949986
Vancouver
Yamauchi H, Hino M, Meguro K, Nakano T, Aoki T, Yamashita Y, et al. A Case of a Novel Perforin Gene Variant in Severe Familial Hemophagocytic Lymphohistiocytosis Type 2 (FHL2). Case Reports in Hematology. 2026;2026(1). doi:10.1155/crh/1949986
BibTeX
@article{Yamauchi2026,
author = {Yamauchi, Hiroshi and Hino, Moeko and Meguro, Kazuyuki and Nakano, Taiji and Aoki, Takahiro and Yamashita, Yoshiharu and Okunushi, Tomoko and Yamamoto, Takeshi and Sato, Hironori and Yasumi, Takahiro and Hirata, Yuiko and Shibata, Hirofumi and Nakajima, Hiroshi and Hamada, Hiromichi},
title = {A Case of a Novel Perforin Gene Variant in Severe Familial Hemophagocytic Lymphohistiocytosis Type 2 (FHL2)},
journal = {Case Reports in Hematology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crh/1949986}
}
EUVIMED